STABILIZATION OF IMMUNOGLOBULINS THROUGH AQUEOUS FORMULATION WITH HISTIDINE AT WEAK ACIDIC TO NEUTRAL PH

The present invention provides, among other aspects, storage stabile aqueous formulations of immunoglobulins with histidine at a mildly acidic to neutral pH. The present invention also provides methods for stabilizing immunoglobulin compositions by formulating with histidine at a mildly acidic to ne...

Full description

Saved in:
Bibliographic Details
Main Authors GNAUER, Lucia, TESCHNER, Wolfgang, KÖLBL, Bernhard, SCHWARZ, Hans-Peter, BUTTERWECK, Harald Arno
Format Patent
LanguageEnglish
French
German
Published 13.12.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention provides, among other aspects, storage stabile aqueous formulations of immunoglobulins with histidine at a mildly acidic to neutral pH. The present invention also provides methods for stabilizing immunoglobulin compositions by formulating with histidine at a mildly acidic to neutral pH. Advantageously, the methods and formulations provided herein allow stabile aqueous compositions of immunoglobulins at mildly acidic to neutral pH useful for parenteral administration.
AbstractList The present invention provides, among other aspects, storage stabile aqueous formulations of immunoglobulins with histidine at a mildly acidic to neutral pH. The present invention also provides methods for stabilizing immunoglobulin compositions by formulating with histidine at a mildly acidic to neutral pH. Advantageously, the methods and formulations provided herein allow stabile aqueous compositions of immunoglobulins at mildly acidic to neutral pH useful for parenteral administration.
Author SCHWARZ, Hans-Peter
TESCHNER, Wolfgang
KÖLBL, Bernhard
GNAUER, Lucia
BUTTERWECK, Harald Arno
Author_xml – fullname: GNAUER, Lucia
– fullname: TESCHNER, Wolfgang
– fullname: KÖLBL, Bernhard
– fullname: SCHWARZ, Hans-Peter
– fullname: BUTTERWECK, Harald Arno
BookMark eNqNys8KgkAQgHEPdejfO8wLdDGDOo62ukPrjrmzCF1EYqNDqGDvT0E9QKePD37LaNYPfVhEDyeYkqErCrEFzoHK0lsuDKfekHUgumZfaMCLV-wd5FyX3nx5Q6JBkxM6kVWAAo3CM2D2-QyEwSovNRqo9Dqa37vnFDa_riLIlWR6G8ahDdPY3UIfXq2qkvhwTJI9xrs_yBtntTd2
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate STABILISATION DES IMMUNOGLOBULINES PAR UNE FORMULATION AQUEUSE ADDITIONNÉE D'HISTIDINE À UN PH FAIBLEMENT ACIDE À NEUTRE
STABILISIERUNG VON IMMUNGLOBULINEN ANHAND EINER WÄSSRIGEN FORMULIERUNG MIT HISTIDIN BEI SCHWACH SAUREN BIS NEUTRALEM PH-WERT
ExternalDocumentID EP4289445A2
GroupedDBID EVB
ID FETCH-epo_espacenet_EP4289445A23
IEDL.DBID EVB
IngestDate Fri Jul 19 12:58:50 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
German
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_EP4289445A23
Notes Application Number: EP20230192151
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231213&DB=EPODOC&CC=EP&NR=4289445A2
ParticipantIDs epo_espacenet_EP4289445A2
PublicationCentury 2000
PublicationDate 20231213
PublicationDateYYYYMMDD 2023-12-13
PublicationDate_xml – month: 12
  year: 2023
  text: 20231213
  day: 13
PublicationDecade 2020
PublicationYear 2023
RelatedCompanies Takeda Pharmaceutical Company Limited
RelatedCompanies_xml – name: Takeda Pharmaceutical Company Limited
Score 3.5070524
Snippet The present invention provides, among other aspects, storage stabile aqueous formulations of immunoglobulins with histidine at a mildly acidic to neutral pH....
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title STABILIZATION OF IMMUNOGLOBULINS THROUGH AQUEOUS FORMULATION WITH HISTIDINE AT WEAK ACIDIC TO NEUTRAL PH
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231213&DB=EPODOC&locale=&CC=EP&NR=4289445A2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV07T8MwELYqQMAGBUR5yQPKFkHjpFWHCuXhNIEkDq1NK5aKmER0SSsaxN_nHNrCAptfsuyTvrvvbN8ZoWspjRcV36mTzMp1kxS5nkmr0IvXwpCyBwyWqADnOOkEwryfWJMGmq1jYeo8oZ91ckRAlAS8V7W-XvwcYnn128rlTTaDpvmdz_uetvKOgawYbaJ5Tp-mzGOu5rpQ0pJhH1h2zzQtG7T1NrDorgIDfXJUUMrit0XxD9BOCpOV1SFq5GUT7bnrj9eaaDde3XdDcQW95RF6G3HbCaPwuT5UwszHYRyLhA0i5ogIfHDMgyETgwDbj4IyMcLg38Ui-h4-DnmAg3DEQy9MKLY5HlP7Adsu1F3MGU6oUL8n4zQ4Rtin3A10WPJ0I54pTTebIydoq5yX-SnCbZXGhnSNzADE5UBaLGLd5p2sAEogSWG2UOvPac7-6TtH-0rO6kVHm1ygrer9I78Eu1xlV7VEvwBAaYoF
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NT8IwFG8IGvGmqBE_ezC7Lcq6QTgQs0862dYJrRAvxM0tchlEZvz3fZ2AXvTWrzTtS36vv9f2vYfQTZpqL9K_UyWJkak6yTM1SY1czV9zLU17wGCJdHAOow4V-sPUmNbQfOMLU8UJ_ayCIwKiUsB7Wenr5c8lllP9rVzdJnNoWtx7vO8oa-sYyIrWJopj9d2YOcxWbBtKSjTqA8vu6bphgrbeAYbdlWBwnyzplLL8faJ4B2g3hsmK8hDVsqKJGvYm8VoT7YXr924orqG3OkJvY25afuA_V5dKmHnYD0MRsUHALBGADY45HTExoNh8FC4TYwz2XSiC7-ETn1NM_TH3HT9yscnxxDWH2LShbmPOcOQKmT0Zx_QYYc_lNlVhybOteGZuvN0cOUH1YlFkpwi3ZRgb0tUSDRCXAWkxiHGXdZIcKEFKcr2FWn9Oc_ZP3zVqUB4GM9jY8BztS5nL3x1tcoHq5ftHdglndJlcVdL9AuaHjPg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=STABILIZATION+OF+IMMUNOGLOBULINS+THROUGH+AQUEOUS+FORMULATION+WITH+HISTIDINE+AT+WEAK+ACIDIC+TO+NEUTRAL+PH&rft.inventor=GNAUER%2C+Lucia&rft.inventor=TESCHNER%2C+Wolfgang&rft.inventor=K%C3%96LBL%2C+Bernhard&rft.inventor=SCHWARZ%2C+Hans-Peter&rft.inventor=BUTTERWECK%2C+Harald+Arno&rft.date=2023-12-13&rft.externalDBID=A2&rft.externalDocID=EP4289445A2